FEATURED

Merck KGaA Agrees to Acquire SpringWorks for $3.9 Billion
Merck KGaA is moving forward with the acquisition of SpringWorks Therapeutics, confirming a definitive agreement at $47 per share in
DEALS

GSK Bolsters Gastrointestinal Cancer Portfolio with $1.15B Acquisition of IDRx
In a strategic move to expand its oncology pipeline, GSK plc (LSE/NYSE: GSK) announced on Tuesday, it has entered into
PRESS RELEASES

Striatech Backs ARVO’s Rising Vision Scientist
At Striatech, advancing the future of ophthalmic research is a central commitment. In partnership with the ARVO Foundation for Eye
EDITOR’S PICKS

The Acceleration of Digitalisation in Pharma in 2025
As we approach the midpoint of the 2020s, the pharmaceutical industry has undergone a radical digital transformation, driven by the
RESOURCES

Pharmaceutical Cold Chain Transportation Made Easy
Protecting temperature-sensitive pharmaceutical goods on their journey from manufacturer to end-user is a major global challenge. A SenseAnywhere White Paper
MANUFACTURING PROJECTS

AstraZeneca Unveils $300 Million Cell Therapy Manufacturing Facility in Rockville, USA
Global biopharmaceutical leader AstraZeneca has officially opened a new $300 million state-of-the-art cell therapy manufacturing facility in Rockville, Maryland, marking
CLINICAL TRIALS

Lilly’s Lepodisiran Slashes Heart Disease Risk Factor by 94% in Phase 2 Trial
Eli Lilly and Company announced groundbreaking Phase 2 results for its investigational siRNA therapy lepodisiran, which reduced lipoprotein(a) [Lp(a)] levels
REGULATORY

Novartis Secures Landmark FDA Approval for Fabhalta® in Rare Kidney Disease
Novartis has received its third U.S. Food and Drug Administration (FDA) approval for Fabhalta® (iptacopan), marking a major milestone as
SELECTED PRODUCTS

In Vivo Assessment of Visual Performance in Mice
The unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for